Option chain shows key data for Jupiter Neurosciences's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Jupiter Neurosciences.

Jupiter Neurosciences (NASDAQ:JUNS) Stock, Option Chain

Jupiter Neurosciences

Jupiter Neurosciences Inc is a clinical stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a unique resveratrol platform product primarily targeting treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to most central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases.

Wall Street

Earnings

Equities

News

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

DGNX

EVTL

ICON

JUNS

NITO

VNCE

US Stocks Mixed; GE Aerospace Posts Upbeat Earnings

movers image

ARQQ

BILI

HSAI

QUBT

RGTI

RICK

RZLV

SKYT

SLQT

TEVA

TSLA

RCI Hospitality, Quantum Computing, Teva Pharmaceutical, Tesla And Other Big Stocks Moving Higher On Monday

Ciena

Movers

BTDR

CIEN

GAMB

HIMX

LQDT

RADX

RIOT

Ciena Posts Strong Sales, Joins Gambling.com, Warner Bros. Discovery And Other Big Stocks Moving Higher On Thursday

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences Inc

Oppenheimer analyst Ken Wong maintains Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) with a Outperform and raises the price target from $130 to $150.

Price Target

Analyst Ratings

SHOP

Oppenheimer Maintains Outperform on Shopify, Raises Price Target to $150

Needham analyst James Ricchiuti reiterates IPG Photonics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IPGP#NASDAQ">IPGP</a>) from Hold to Hold.

Reiteration

IPGP

Needham Reiterates Hold on IPG Photonicsto Hold

Needham analyst Charles Shi reiterates Axcelis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACLS#NASDAQ">ACLS</a>) from Hold to Hold.

ACLS

Needham Reiterates Hold on Axcelis Technologiesto Hold

Needham analyst Ryan Koontz reiterates Ceragon Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNT#NASDAQ">CRNT</a>) with a Buy and maintains $6 price target.

CRNT

Needham Reiterates Buy on Ceragon Networks, Maintains $6 Price Target

Seaport Global analyst David Joyce downgrades Endeavor Gr Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EDR#NYSE">EDR</a>) from Neutral to Sell and maintains the price target from $27.5 to $27.5.

Downgrades

Seaport Global Downgrades Endeavor Gr Hldgs to Sell, Maintains Price Target to $27.5

Seaport Global analyst David Joyce downgrades TKO Group Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TKO#NYSE">TKO</a>) from Buy to Neutral.

Seaport Global Downgrades TKO Group Holdings to Neutral

Goldman Sachs analyst Richard Edwards downgrades On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) from Buy to Neutral and maintains the price target from $57 to $57.

ONON

Goldman Sachs Downgrades On Holding to Neutral, Maintains Price Target to $57

While Marriott International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) performed <a href="https://www.benzinga.com/news/earnings/25/02/43629316/marriott-tops-q4-estimates-as-2025-outlook-pressures-stock">better</a> than analysts&#8217; expectations in the fourth quarter, its guidance missed the first-quarter estimates. However, the company highlighted its growing digital strength and loyalty program during its earnings call.
What Happened: The hotel giant announced a surge in digital engagement, including a near 30% year-over-year increase in Marriott Bonvoy app downloads in 2024. It added over 31 million new Bonvoy members over the last year, bringing the total to nearly 228 million.
&#8220;Bonvoy member penetration of room nights achieved historic highs in the fourth quarter at 73% in the U.S. and 66% globally,&#8221; said CEO Anthony Capuano.
Marriott Bonvoy is a free loyalty program where guests earn and redeem points for stays at Marriott hotels, including brands like Ritz-Carlton, St. Regis, JW Marriott, Sheraton, Westin, and Renaissance.
Capuano added, &#8220;Our digital channels and mobile in particular remain key drivers of direct bookings at a lower cost to our owners.
&#8220;We're excited about enhancing the customer experience across all of our digital channels through the multi-year digital transformation we have underway.&#8221; Capuano hinted that the company expects to roll out the transformation strategies &#8220;a little later this year.&#8221;
The company&#8217;s focus on digital extends beyond just its own platforms. Marriott has forged strategic partnerships in its &#8220;co-brand credit cards&#8221; with companies like Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Starbucks Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>), further integrating travel into consumers' daily lives, said the CEO.
See Also: <a href="https://www.benzinga.com/25/02/43648935/doordash-delivers-more-than-dinner-cfo-says-gained-share-in-new-verticals-like-grocery-and-retail-beyond-restaurants-thanks-to-exploding-monthly-users-record-order-frequency">DoorDash Surges To 42M Monthly Users As Grocery And Retail Sales Soar Amid Record Order Frequency</a>
Why It Matters: The company reported fourth-quarter <a href="https://www.benzinga.com/news/earnings/25/02/43629316/marriott-tops-q4-estimates-as-2025-outlook-pressures-stock">sales growth</a> of 5.5% year-on-year to $6.429 billion, beating the analyst consensus estimate of $6.379 billion. Adjusted EPS of $2.45 beat the consensus estimate of $2.38.
However, its first-quarter adjusted earnings are expected to range from $2.20 to $2.26 per share, whereas <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> expects earnings of $2.360 per share.
The shares of the company fell 5.40% to $288 apiece on Tuesday after missing the first-quarter guidance expectations. The shares rose by 0.04% in after-hours.
Price Action: The stock was up 0.042% in premarket on Wednesday, whereas the exchange-traded fund tracking Nasdaq 100 index, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.11% in premarket.
MAR shares have gained 4.94% on a year-to-date basis, whereas it was up by only 5.74% over the last year.
The average price target among 28 <a href="https://www.benzinga.com/quote/MAR/analyst-ratings">analysts tracked by Benzinga</a> is $260.74 with a ‘hold' rating. The estimates range from $185 to $330 apiece. Recent ratings from Wells Fargo, Evercore ISI Group, and Argus Research suggest a $315 target, implying a potential upside of 9.33%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/MAR/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="385" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12040106/MAR-ANR-1024x385.png" alt="" class="wp-image-778122" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12040106/MAR-ANR-1024x385.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12040106/MAR-ANR-300x113.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12040106/MAR-ANR-768x289.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12040106/MAR-ANR.png 1063w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43647586/coca-cola-won-overall-share-from-pepsi-maaza-crosses-1-billion-milestone-analyst-says-never-seen-fundamentals-this-good-amid-strong-2025-outlook">Coca-Cola &#8216;Won Overall Share&#8217; From Pepsi: Analyst Says &#8216;Never Seen Fundamentals This Good,&#8217; Amid Strong 2025 Outlook</a></li>
</ul>
Photo via Shutterstock

Analyst Color

Earnings Beats

Market Summary

Broad U.S. Equity ETFs

Futures

ETFs

General

SBUX

UBER

Marriott's Digital Penetration Hits 'Historic Highs' As Bonvoy App Downloads Soar Adding 31 Million New Members

The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, with the index remaining in the &#8220;Neutral&#8221; zone on Tuesday.
U.S. stocks settled mixed on Tuesday, as investors digested comments from Federal Reserve Chair Jerome Powell. The Fed chief reiterated that the central bank is in no hurry to cut interest rates during his testimony before the Senate Banking Committee, offering little support for risk assets.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) fell by over 4%, reaching the lowest levels in eleven weeks, pressured by weak January auto sales in China. Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) and Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) shares settled higher on Tuesday following a report from The Information indicating the companies partnered to develop AI features for iPhone user in China.
On the economic data front, the NFIB Small Business Optimism Index declined to 102.8 in January compared to 105.1 in the previous month, and down from estimates of 104.6.
Most sectors on the S&amp;P 500 closed on a positive note, with consumer staples, energy and real estate stocks recording gains on Tuesday. However, consumer discretionary and health care stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 123 points to 44,593.65 on Tuesday. The S&amp;P 500 rose 0.03% to 6,068.50, while the Nasdaq Composite fell 0.36% at 19,643.86 during Tuesday's session.
Investors are awaiting earnings results from CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), The Kraft Heinz Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) and Cisco Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) today.
At a current reading of 46.46, the index remained in the &#8220;Neutral&#8221; zone on Tuesday, versus a prior reading of 46.54.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

Long Ideas

Pre-Market Outlook

AAPL

BABA

CSCO

Dow Gains Over 100 Points Following Powell Comments: Fear & Greed Index Remains In 'Neutral' Zone

ERIC

Ericsson-backed Aduna Partners Announced The Addition Of KDDI Corporation As An Equity Partner

Piper Sandler analyst Arvind Ramnani reiterates Upstart Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPST#NASDAQ">UPST</a>) with a Overweight and raises the price target from $85 to $105.

UPST

Piper Sandler Reiterates Overweight on Upstart Hldgs, Raises Price Target to $105

Piper Sandler analyst Clarke Jeffries maintains Shopify (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHOP#NYSE">SHOP</a>) with a Neutral and raises the price target from $94 to $104.

Piper Sandler Maintains Neutral on Shopify, Raises Price Target to $104

Piper Sandler analyst Brent Bracelin maintains Freshworks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRSH#NASDAQ">FRSH</a>) with a Overweight and raises the price target from $20 to $24.

FRSH

Piper Sandler Maintains Overweight on Freshworks, Raises Price Target to $24

On Tuesday, Alphabet Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google confirmed that its annual developer conference, Google I/O 2025, will take place on May 20-21 at the Shoreline Amphitheater in Mountain View, California.
What Happened: As one of the most anticipated tech events of the year, Google I/O brings together developers, engineers, and tech enthusiasts.
The company will use the event to showcase major advancements in artificial intelligence, Android, and cloud computing.
See Also:&nbsp;<a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision" target="_blank" rel="noreferrer noopener">Meta's AI Push Could Add $100 Per Share While Tesla Faces EV Headwinds: Top Analyst</a>
The first day, May 20, will begin with the highly anticipated Google Keynote, followed by the Developer Keynote. The rest of the day will feature product demos, Q&amp;A sessions, and networking events, including a developer block party.
The second day, May 21, will continue with in-depth technical sessions and more opportunities for attendees to engage with Google engineers.
Registration for the free event is now open, and for those unable to attend in person, the keynotes will be streamed live on YouTube.
Subscribe to the&nbsp;<a href="https://bztechtrends.beehiiv.com/subscribe" target="_blank" rel="noreferrer noopener">Benzinga Tech Trends newsletter</a>&nbsp;to get all the latest tech developments delivered to your inbox.
What To Expect: Google I/O has traditionally been the stage for unveiling major software updates, including new versions of Android and advancements in Google's AI initiatives. Last year, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38825276/google-io-2024-to-spotlight-ai-innovations-and-new-monetization-opportunities-analy">the company introduced</a> Gemini Live and showcased multiple AI-driven features.
This year, AI is expected to take center stage once again. Google could announce new updates for Gemini AI, unveil Android 16, and improvements to Google Search, Assistant, and Workspace.
There is also speculation about whether Google will unveil the Pixel 9a at the event. In past years, Google introduced its Pixel &#8220;a&#8221; series at I/O, but last year, it broke tradition by revealing the Pixel 8a through a marketing campaign instead.
Check out more of Benzinga's Consumer Tech coverage by&nbsp;<a href="https://www.benzinga.com/topic/consumer-tech" target="_blank" rel="noreferrer noopener">following this link</a>.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/media/25/02/43646042/elon-musks-97-4-billion-openai-takeover-bid-reportedly-not-received-by-chatgpt-parent-another-one-of-his-tactics-says-sam-altman" target="_blank" rel="noreferrer noopener">Elon Musk&#8217;s $97.4 Billion OpenAI Takeover Bid Reportedly Not Received By ChatGPT Parent: ‘Another One Of His Tactics,&#8217; Says Sam Altman</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Tech

GOOG

GOOGL

Google I/O 2025 Officially Set For May — Here's What To Expect, From AI Breakthroughs To The Future Of Android And Pixel 9a

Morgan Stanley analyst Michael Ulz downgrades Third Harmonic Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THRD#NASDAQ">THRD</a>) from Overweight to Equal-Weight and lowers the price target from $20 to $5.

THRD

Morgan Stanley Downgrades Third Harmonic Bio to Equal-Weight, Lowers Price Target to $5

Meta Platforms Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is reportedly in negotiations to acquire&nbsp;FuriosaAI Inc., a Seoul-based AI chip startup. The acquisition deal is expected to&nbsp;be finalized as early as&nbsp;this month.
What Happened: Mark Zuckerberg&#8216;s Meta is in discussions to acquire FuriosaAI, a South Korean AI chip startup founded by June Paik, a former Samsung (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>)and Advanced Micro Devices (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>) engineer, according to a Forbes <a href="https://www.forbes.com/sites/johnkang/2025/02/11/meta-in-talks-to-buy-korean-ai-chip-startup-founded-by-samsung-engineer/">report</a> on Tuesday. FuriosaAI specializes in developing accelerators that optimize AI applications and has created its own AI chip, Warboy in 2021, after which it launched the advanced accelerator chip RNGD in August.
"RNGD will be an ideal choice for the large-scale deployment of advanced generative AI models such as Meta&#8217;s Llama 2 and Llama 3," stated FuriosaAI.
CEO Paik has previously highlighted the need for an alternative semiconductor ecosystem, citing the high cost and limited supply of Nvidia&#8217;s AI accelerators. FuriosaAI&#8217;s models reportedly offer a more cost-effective solution, with system chip construction costs amounting to about half of Nvidia&#8217;s.
SEE ALSO: <a href="https://www.benzinga.com/markets/equities/25/02/43591228/sam-altmans-openai-set-to-finalize-in-house-ai-chip-reducing-dependence-on-nvidia-report">Sam Altman&#8217;s OpenAI Set To Finalize In-House AI Chip, Reducing Dependence On Nvidia: Report</a>
Why It Matters: This move by the Zuckerberg-led company comes in the wake of aggressive AI initiatives that have been driving the company&#8217;s growth. According to Wedbush analyst Dan Ives, <a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision">Meta&#8217;s AI-driven monetization</a> strategy could potentially add an incremental $100 per share.
The acquisition talks are also happening at a time when Meta Platforms is looking to challenge&nbsp;Nvidia Corp&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)&nbsp;and lessen its strong dependence on the world&#8217;s leading GPU manufacturer for AI chips. Last month, Meta revealed that its capital expenditures could reach up to $65 billion in 2025, with a substantial share dedicated to AI infrastructure investments.
Conrad van Tienhoven, a portfolio manager at Riverpark Capital told Bloomberg, "I have long viewed Meta as the biggest beneficiary of AI outside of maybe Nvidia, and I think more people are coming around to that idea.&#8221; Tienhoven elucidated that Meta's investment has reshaped its approach to ad targeting and measurement, leading to enhanced growth and increased average revenue per user.
<ul>
<li>READ MORE: <a href="https://www.benzinga.com/insights/news/25/02/43644404/100-invested-in-nvidia-20-years-ago-would-be-worth-this-much-today">$100 Invested In NVIDIA 20 Years Ago Would Be Worth This Much Today</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

NVDA

SSNLF

Mark Zuckerberg's Meta Eyes Acquisition Of Korean AI Chip Startup Founded By Former Samsung And AMD Engineer

Former Treasury Secretary Larry Summers warned of heightened inflation risks, citing tight labor markets and potential policy shifts, as markets dramatically scaled back expectations for Federal Reserve rate cuts in 2025.
What Happened: &#8220;This is probably the most sensitive moment we&#8217;ve had for an escalation in inflation since the policy errors of 2021,&#8221; Summers <a href="https://www.bloomberg.com/news/articles/2025-02-11/summers-sees-biggest-inflation-breakout-risk-since-2021-errors">said</a> on Bloomberg Television&#8217;s Wall Street Week, pointing to January&#8217;s strong wage growth data and tightening labor market conditions.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is probably the most sensitive moment we've had for an escalation in inflation since the policy errors of 2021 that set off the significant inflation that we had.<a href="https://t.co/A1Y5cUvhbN">https://t.co/A1Y5cUvhbN</a>
&mdash; Lawrence H. Summers (@LHSummers) <a href="https://twitter.com/LHSummers/status/1889435210644599002?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Economist Peter Schiff echoed inflation concerns, arguing on social media platform X that the Federal Reserve&#8217;s previous 40% increase in money supply inherently creates inflation. &#8220;It&#8217;s not that money supply growth could cause inflation, but that, by definition, it is inflation. It&#8217;s because the Fed creates inflation that prices go up.&#8221; Schiff wrote. 
Meanwhile, Fed Chair Jerome Powell maintained a <a href="https://in.benzinga.com/economics/macro-economic-events/25/02/43628752/feds-powell-reiterates-no-hurry-to-cut-interest-rates-as-inflation-remains-somewhat-elevated">cautious stance during Tuesday&#8217;s Senate testimony</a>, emphasizing that policymakers are in no &#8220;hurry&#8221; to adjust rates while inflation remains &#8220;somewhat elevated.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Fed Chair Powell said a 40% increase in the money supply in a short period of time could possibly cause some inflation. It&#39;s not that money supply growth could cause inflation, but that, by definition, it is inflation. It&#39;s because the Fed creates inflation that prices go up.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1889390023515975824?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The S&amp;P 500, tracked by SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), has risen 4.11% over the past month, trading at $605.31 as of Tuesday. The Nasdaq-100, tracked by Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), is up 4.44% in the same period, trading at $527.99. Meanwhile, Dow Jones Industrial Average Futures are at 44,678.00 USD, down 30.00 points or 0.06% today, according to <a href="https://www.benzinga.com/pro/">data from Benzinga Pro</a>.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43646506/dan-ives-says-palantir-could-be-next-oracle-or-salesforce-as-ai-boom-drives-massive-software-spending-highlights-8-10x-multiplier-effect">Dan Ives Says Palantir Could Be Next Oracle Or Salesforce As AI Boom Drives Massive Software Spending, Highlights 8-10x Multiplier Effect</a>
Why It Matters: Recent economic indicators have <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says">fueled these concerns</a>. The University of Michigan&#8217;s consumer sentiment survey showed one-year inflation expectations jumping to 4.3%, while the U.S. five-year breakeven rate climbed to 2.59%, up from 1.89% in September.
Bank of America economist Aditya Bhave suggested that &#8220;the Fed&#8217;s rate-cutting cycle is over,&#8221; as January&#8217;s employment data showed the labor market stabilizing around full employment. The unemployment rate unexpectedly dropped to 4.1%, with wage growth accelerating despite <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says">weather-impacted headline numbers</a>.
Goldman Sachs economists noted that markets might be underpricing inflation risks, particularly given the potential impacts from proposed tariff increases and uncertainty in <a href="https://www.benzinga.com/economics/macro-economic-events/25/02/43608052/traders-rethink-interest-rate-path-as-inflation-concerns-resume-feds-rate-cutting-cycle-is-over-economist-says">trade policy outcomes</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43646173/bitcoin-ethereum-dogecoin-dip-even-as-fed-chair-powell-says-no-to-cbdcs-analyst-says-btc-under-consolidation-but-next-big-move-could-be-likely">Bitcoin, Ethereum, Dogecoin Dip Even As Fed Chair Powell Says No To CBDC: Analyst Says BTC Under Consolidation But &#8216;Next Big Move&#8217; Likely</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Economics

Federal Reserve

Larry Summers And Peter Schiff Warn Of Rising Inflation Risks As Markets Slash Fed Rate Cut Expectations: 'Most Sensitive Moment'

Shares of Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) have skyrocketed by 17.47% over the last 17 days, reregistering one of the longest winning streaks for the company led by Mark Zuckerberg, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-1024x576.png" alt="" class="wp-image-777978" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025719/Meta-Over-Last-18-Days.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
What Happened: The stock trades at $719.80 apiece as of Tuesday&#8217;s close, which is about 0.7% shy of its 52-week high of $725.01 per share.
Despite the constant surge in the stock, Meta&#8217;s over-optimistic momentum indicators hint at a likely pullback.
The company&#8217;s simple daily moving averages hinted at a bullish uptrend, owing to strength in the stock, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. The share price was much above its 200-day simple moving average of $548.26, and 50-day average of $630.51. It is also higher than its eight-day average of $707.43 and the 20-day average of $665.82.
The momentum indicators were also very strong. The relative strength index of 80.70, coupled with a positive MACD (moving average convergence/divergence) indicator of 28.44 showed that the stock was overbought. These strong upward trends suggest that the stock could be nearing exhaustion, signaling a potential short-term pullback or consolidation phase.
<figure class="wp-block-image size-large"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="1024" height="576" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-1024x576.png" alt="" class="wp-image-777987" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-1024x576.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-300x169.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-768x432.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart-1536x864.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025743/Meta-tech-Chart.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/25/02/43491799/meta-ai-models-clearly-behind-deepseek-says-analysts-after-mark-zuckerberg-admitted-deepseek-did-some-novel-things-were-still-digesting">Meta AI Models &#8216;Clearly Behind&#8217; DeepSeek, Says Analyst After Mark Zuckerberg Admits DeepSeek Did Some Novel Things &#8216;We&#8217;re Still Digesting&#8217;</a>
Why It Matters: Despite the recent stock surge, Meta faces <a href="https://www.benzinga.com/general/market-summary/25/02/43491799/meta-ai-models-clearly-behind-deepseek-says-analysts-after-mark-zuckerberg-admitted-deepseek-did-some-novel-things-were-still-digesting">headwinds</a> in the AI race, according to Piper Sandler. Their research note dated Feb. 4, positioned DeepSeek&#8217;s AI model ahead of Meta's latest Llama model.
However, Wedbush analyst Dan Ives <a href="https://www.benzinga.com/25/02/43646615/top-analyst-says-metas-ai-push-could-add-100-per-share-while-tesla-faces-ev-headwindswhy-hes-still-bullish-on-musks-robotics-vision">remains bullish</a>, he recently highlighted Meta&#8217;s AI monetization strategy on CNBC.
&#8220;It&#8217;s about monetizing those three and a half billion DAUs,&#8221; he said, adding that AI innovations &#8220;could be an incremental $100 per share&#8221; for Meta as the company ramps up its efforts.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">We believe Meta is in a very strong position to further monetize AI over the coming years as Zuck drives the vision and puts massive cap-ex behind this AI initiative in 2025 <a href="https://twitter.com/CNBCWEX?ref_src=twsrc%5Etfw">@CNBCWEX</a> <a href="https://twitter.com/FrankCNBC?ref_src=twsrc%5Etfw">@FrankCNBC</a> &#x1f525;&#x1f3c6;&#x1f402;&#x1f37f;&#x1f4fa;&#x1f447; <a href="https://twitter.com/CNBC?ref_src=twsrc%5Etfw">@CNBC</a> <a href="https://t.co/DmU2qc3ag8">https://t.co/DmU2qc3ag8</a>
&mdash; Dan Ives (@DivesTech) <a href="https://twitter.com/DivesTech/status/1889294401362387207?ref_src=twsrc%5Etfw">February 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Price Action: Meta rose by 0.33% on Tuesday and advanced further by 0.01% in after-hours, whereas the exchange-traded fun tracking Nasdaq 100 index, Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.24%.
Meta shares have gained 20.12% on a year-to-date basis, whereas it was up by 53.51% over the last year.
The average price target among 43 <a href="https://www.benzinga.com/quote/META/analyst-ratings">analysts tracked by Benzinga</a> is $731.76 with a ‘buy' rating. The estimates range from $575 to $935 apiece. Recent ratings from Tigress Financial, UBS, and Citigroup suggest a $833.67 target, implying a potential upside of 15.81%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/META/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="381" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-1024x381.png" alt="" class="wp-image-777974" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-1024x381.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn-768x285.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12025539/Meta-ANR-FIn.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43647586/coca-cola-won-overall-share-from-pepsi-maaza-crosses-1-billion-milestone-analyst-says-never-seen-fundamentals-this-good-amid-strong-2025-outlook">Coca-Cola &#8216;Won Overall Share&#8217; From Pepsi: Analyst Says &#8216;Never Seen Fundamentals This Good,&#8217; Amid Strong 2025 Outlook </a></li>
</ul>
Image via Shutterstock

Technicals

Meta Stock Surges 17.47% In 17 Days, Marking One Of Its Longest Winning Streaks—Analysts Say There's Still Room For Double-Digit Growth For Mark Zuckerberg's Company

ACRE

AEIS

AEMD

ALCO

ALKS

AMWL

ASND

ASPN

ATRC

AVXL

AYTU

BIIB

BROS

BXMT

CAMT

CGNX

CHEF

CNCK

CNDT

COOP

CRBG

CRSR

CRWS

CTRE

CWST

DENN

EPRT

EQIX

FCPT

FSLY

GAIN

GILT

GLPG

GNRC

GOLD

GROW

HCSG

HOOD

HUBS

IREN

KRNT

MKSI

MLYS

MMLP

NMTC

OPRT

OTLY

PAYC

PEGA

PLMR

PODC

PXLW

PYPD

QDEL

QMCO

QTWO

Earnings Scheduled For February 12, 2025

Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>) will release its fourth-quarter financial results, before the opening bell, <a href="https://www.benzinga.com/quote/biib/earnings">on Wednesday, Feb. 12, 2025.</a>
Analysts expect the Cambridge, Massachusetts-based company to report quarterly earnings at $3.36 per share, up from $2.95 per share in the year-ago period. Biogen projects quarterly revenue of $2.42 billion, compared to $2.39 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
Sage Therapeutics recently announced that its Board of Directors initiated a process to explore strategic alternatives and rejected the unsolicited, nonbinding proposal it received from Biogen for $7.22 per share.
Biogen shares fell 2.2% to close at $139.39 on Tuesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/BIIB/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li>Citigroup analyst Geoff Meacham maintained a Neutral rating and cut the price target from $190 to $160 on Jan. 28, 2025. This analyst has an accuracy rate of 61%.</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and slashed the price target from $190 to $165 on Jan. 10, 2025. This analyst has an accuracy rate of 73%.</li>
<li>BMO Capital analyst Evan Seigerman downgraded the stock from Outperform to Market Perform and cut the price target from $230 to $164 on Dec. 20, 2024. This analyst has an accuracy rate of 62%.</li>
<li>Needham analyst Ami Fadia downgraded the stock from Buy to Hold with a price target of $270 on Nov. 18, 2024. This analyst has an accuracy rate of 67%.</li>
<li>Oppenheimer analyst Jay Olson maintained an Outperform rating and cut the price target from $270 to $255 on Oct. 31, 2024. This analyst has an accuracy rate of 63%.</li>
</ul>
Considering buying BIIB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="572" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-1024x572.png" alt="" class="wp-image-778054" style="width:505px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-1024x572.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98-768x429.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/12032109/image-98.png 1113w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/02/43623929/wall-streets-most-accurate-analysts-spotlight-on-3-utilities-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Spotlight On 3 Utilities Stocks Delivering High-Dividend Yields</a></li>
</ul>

Biogen Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Press Releases

Jupiter Neurosciences, Inc. Announces Pricing of $11 million Initial Public Offering and Listing on Nasdaq

Jupiter Neurosciences, Inc. Announces Closing of $11 million Initial Public Offering

Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials

Jupiter Neurosciences Partners with Zina Biopharmaceuticals to Advance Phase 2a Parkinson's Trial

Jupiter Neurosciences Announces JOTROL Manufacturing Agreement with Catalent to Support Phase 2a Parkinson's Trial

Jupiter Neurosciences Addresses Market Volatility as it Remains Focused on Advancing Clinical and Commercial Milestones

Comments

Jupiter Neurosciences

Jupiter Neurosciences (JUNS) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga